Vontobel Holding Ltd. Inovio Pharmaceuticals, Inc. Transaction History

Vontobel Holding Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.97 - $5.2 $599,482 - $1.05 Million	-201,846 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.99 - $7.46 $61,327 - $91,683	12,290 Added 6.48%	201,846 $1.01 Million
Q3 2021 Oct 29, 2021	BUY	$7.16 - $9.69 $557,048 - $753,882	77,800 Added 69.62%	189,556 $1.36 Million
Q2 2021 Aug 06, 2021	SELL	$6.23 - $10.03 $37,672 - $60,651	-6,047 Reduced 5.13%	111,756 $1.04 Million
Q1 2021 May 11, 2021	SELL	$8.81 - $16.96 $53,961 - $103,880	-6,125 Reduced 4.94%	117,803 $1.09 Million
Q4 2020 Feb 12, 2021	BUY	$8.5 - $12.85 $1.05 Million - $1.59 Million	123,928 New	123,928 $1.1 Million

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $1.41B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.